STATE STREET CORP - DIPLOMAT PHARMACY INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$8,178,000
-14.3%
2,044,470
+5.0%
0.00%0.0%
Q3 2019$9,542,000
-17.2%
1,947,256
+2.9%
0.00%0.0%
Q2 2019$11,527,000
-4.9%
1,892,811
-9.3%
0.00%0.0%
Q1 2019$12,124,000
-52.5%
2,086,832
+10.0%
0.00%
-50.0%
Q4 2018$25,528,000
-25.1%
1,896,608
+8.0%
0.00%
-33.3%
Q3 2018$34,089,000
-12.6%
1,756,368
+15.1%
0.00%0.0%
Q2 2018$39,010,000
+49.5%
1,526,119
+17.8%
0.00%
+50.0%
Q1 2018$26,096,000
-11.9%
1,295,167
-12.3%
0.00%0.0%
Q4 2017$29,624,000
+12.7%
1,476,100
+16.3%
0.00%0.0%
Q3 2017$26,289,000
+40.4%
1,269,360
+0.3%
0.00%0.0%
Q2 2017$18,718,000
-5.7%
1,265,089
+1.7%
0.00%0.0%
Q1 2017$19,841,000
+44.5%
1,244,255
+14.2%
0.00%
+100.0%
Q4 2016$13,730,000
-48.3%
1,089,708
+14.8%
0.00%
-66.7%
Q3 2016$26,576,000
-22.5%
948,965
-3.1%
0.00%
-25.0%
Q2 2016$34,301,000
+41.0%
979,821
+10.3%
0.00%
+33.3%
Q1 2016$24,331,000
+0.0%
888,040
+24.9%
0.00%0.0%
Q4 2015$24,323,000
+24.6%
710,800
+4.6%
0.00%
+50.0%
Q3 2015$19,516,000
-27.0%
679,362
+13.8%
0.00%
-33.3%
Q2 2015$26,716,000
+22.6%
596,999
-5.3%
0.00%
+50.0%
Q1 2015$21,799,000
+395.4%
630,357
+291.9%
0.00%
Q4 2014$4,400,000160,8370.00%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q3 2023
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 445,200$7,101,0001.80%
Redmile Group, LLC 1,254,342$20,007,0001.30%
Irving Magee Investment Management 166,505$2,656,0001.02%
BROADVIEW ADVISORS LLC 376,050$5,998,0000.83%
Sivik Global Healthcare LLC 101,000$1,611,0000.75%
FRONTIER CAPITAL MANAGEMENT CO LLC 5,455,461$87,015,0000.64%
Iguana Healthcare Management, LLC 75,000$1,196,0000.59%
RIVERBRIDGE PARTNERS LLC 1,464,286$23,355,0000.47%
HERMES INVESTMENT MANAGEMENT LTD 1,772,777$28,276,0000.46%
Endurant Capital Management LP 85,043$1,356,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders